Bhupinder Virk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bhupinder Virk has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- David Weinkove
Durham University
2 shared publications - Jie Jia
Department of Clinical Nutrition, Shanghai Jiaotong University, College of Health Science and Technology, Shanghai, China
2 shared publications Adelaide Raimundo
School of Biological and Biomedical Sciences, Durham University, South Road, Durham DH1 3LE, UK
1 shared publication- Claire Maynard
Department of Biosciences, Durham University, Durham, UK
1 shared publication - David Gems
Institute of Healthy Ageing, and Research Department of Genetics, Evolution and Environment, University College London
1 shared publication - David P. Dixon
School of Biological and Biomedical Sciences, University of Durham, South Road, Durham DH1 3LE, UK
1 shared publication
Latest Publications
- Open Access
- 1 February 2016
- Published by Elsevier in Cell Reports
- Vol. 14 (7) , 1611-1620
Folate Acts in E. coli to Accelerate C. elegans Aging Independently of Bacterial Biosynthesis
- 1 February 2016
- Published by Elsevier in Cell Reports
- Vol. 14 (7) , 1611-1620
Open AccessFolate Acts in E. coli to Accelerate C. elegans Aging Independently of Bacterial Biosynthesis
- Open Access
- 31 July 2012
- Published by Springer Nature in BMC Biology
- Vol. 10 (1) , 67
Excessive folate synthesis limits lifespan in the C. elegans: E. coliaging model
Background: Gut microbes influence animal health and thus, are potential targets for interventions that slow aging. Live E. coli provides the nematode worm Caenorhabditis elegans with vital micronutrients, such as folates that cannot be synthesized by animals. However, the microbe also limits C. elegans lifespan. Understanding these interactions may shed light on how intestinal microbes influence mammalian aging. Results: Serendipitously, we isolated an E. coli mutant that slows C. elegans aging. We identified the disrupted gene to be aroD, which is required to synthesize aromatic compounds in the microbe. Adding back aromatic compounds to the media revealed that the increased C. elegans lifespan was caused by decreased availability of para-aminobenzoic acid, a precursor to folate. Consistent with this result, inhibition of folate synthesis by sulfamethoxazole, a sulfonamide, led to a dose-dependent increase in C. elegans lifespan. As expected, these treatments caused a decrease in bacterial and worm folate levels, as measured by mass spectrometry of intact folates. The folate cycle is essential for cellular biosynthesis. However, bacterial proliferation and C. elegans growth and reproduction were unaffected under the conditions that increased lifespan. Conclusions: In this animal:microbe system, folates are in excess of that required for biosynthesis. This study suggests that microbial folate synthesis is a pharmacologically accessible target to slow animal aging without detrimental effects.
- 31 July 2012
- Published by Springer Nature in BMC Biology
- Vol. 10 (1) , 67
Open AccessExcessive folate synthesis limits lifespan in the C. elegans: E. coliaging model
Background: Gut microbes influence animal health and thus, are potential targets for interventions that slow aging. Live E. coli provides the nematode worm Caenorhabditis elegans with vital micronutrients, such as folates that cannot be synthesized by animals. However, the microbe also limits C. elegans lifespan. Understanding these interactions may shed light on how intestinal microbes influence mammalian aging. Results: Serendipitously, we isolated an E. coli mutant that slows C. elegans aging. We identified the disrupted gene to be aroD, which is required to synthesize aromatic compounds in the microbe. Adding back aromatic compounds to the media revealed that the increased C. elegans lifespan was caused by decreased availability of para-aminobenzoic acid, a precursor to folate. Consistent with this result, inhibition of folate synthesis by sulfamethoxazole, a sulfonamide, led to a dose-dependent increase in C. elegans lifespan. As expected, these treatments caused a decrease in bacterial and worm folate levels, as measured by mass spectrometry of intact folates. The folate cycle is essential for cellular biosynthesis. However, bacterial proliferation and C. elegans growth and reproduction were unaffected under the conditions that increased lifespan. Conclusions: In this animal:microbe system, folates are in excess of that required for biosynthesis. This study suggests that microbial folate synthesis is a pharmacologically accessible target to slow animal aging without detrimental effects.